Family offices are driven by personalities and ideals that cannot be understood as part of an industry pattern. Relationship building is therefore more intimate than transactional
Rocket Lab's latest funding round is aimed at helping the New Zealand-founded company grow into new markets and target new business opportunities
Australia’s Future Fund has led a $140 million Series E round for Rocket Lab, a US-based space technology company that operates primarily in New Zealand.
Chinese co-working space operator Ucommune, formerly named UrWork, has raised $200 million in Series D funding led by All-Stars Investment, with participation from CEC Capital.
Hillhouse Capital and Quan Capital have led a $93 million Series B round for NextCure, a US-based biopharmaceutical company focused on cancer and other diseases.
Yup S. Kim, a senior portfolio manager for private equity and special opportunities, at Alaska Permanent Fund Corporation (APFC) discusses co-investment, accessing Asia, and allocating to permanent capital structures
Chinese online shopping and social networking business Mogujie has filed to list in the US. The company's investors include Tencent Holdings, Trustbridge Partners, and Hillhouse Capital.
Fenox Venture Capital, a VC firm based in Silicon Valley, has partnered with Japanese entertainment company Sega Sammy Holdings to launch a $20 million fund to invest in advanced technologies globally.
China and US-based XtalPi has raised $61 million this year from investors impressed its use of quantum physics, computational chemistry, and artificial intelligence to bring greater certainty to drug development
Vivo Capital and Orbimed have co-led an $80 million Series B funding round for US and China-based Terns Pharmaceuticals.
Innovusion, a US-based developer of Lidar technology for autonomous vehicles, has raised a $30 million Series A round led by Eight Roads Ventures China and Nio Capital, a unit of Chinese electric vehicle maker Nio.
Bcause, a US-based cryptocurrency services company backed by SBI Holdings has received a commitment of undisclosed size from China Health Checkmate (CHC) to support an Asian expansion.
The escalating Sino-US trade war and tighter US regulatory scrutiny of inbound deals has promoted Chinese buyers to pursue investments in new markets, but they must be prepared to overcome opposition in these destinations as well, the China M&A Forum...
Chinese investment in US biotech – and its ability to import intellectual property for domestic drug development – looks set to be a casualty of worsening relations between the two nations
New trade legislation in the US is set to have important ramifications for Chinese private equity deal making in a range of data-related technology segments. Macro effects, however, may be muted
Netradyne, a US and India-based developer of artificial intelligence (AI) technology focused on automotive applications, has raised $21 million in Series B funding from a group of VC and strategic investors.
California Public Employees’ Retirement System (CalPERS) has appointed Yu Ben Meng, who has spent the last three years as deputy CIO of China’s State Administration of Foreign Exchange (SAFE) as its new CIO.
Hanon Systems, an auto parts manufacturer owned by Hahn & Company and formerly known as Halla Visteon Climate Control, has agreed a $1.23 billion bolt-on acquisition of Magna International’s fluid pressure and controls business.
Chinese healthcare-focused GP HighLight Capital is set to exit its position in US-based biotechnology company Bonti after Allergan agreed to acquire the business for $195 million, plus additional payments if certain development targets are met.
Fosun Group and Morningside Venture Capital lead a $50 million Series C round to support PingCap's US-China cloud database services push
Silver Lake has invested $600 million in AMC Entertainment Holdings, a US cinema chain owned by Dalian Wanda Group, a once acquisitive Chinese conglomerate now said to be retreating from overseas markets.
The Carlyle Group has paid an undisclosed sum for a significant minority stake in Ambio, a US-based pharmaceuticals company with substantial operations in China.
Special purpose acquisition companies, or SPACs, are staging a modest comeback in Asia on the back of a resurgence in the US. These structures offer considerable upside, but they aren’t for everyone
Japan Post Investment Corporation (JPIC), a direct investment unit launched by Japan Post Bank and Japan Post Insurance earlier this year, has joined a $94 million round for Japan-founded and US-based data company Cloudian.